ESMO Public Policy Webinar on the Clinical Trials Regulation and its Impact on Oncology
Date: Tuesday 12 October 2021
Time: 13:00-14:00 CEST
The Clinical Trials Regulation, which was adopted in April 2014 and is foreseen to become applicable in January 2022, will introduce major changes to how clinical trials will be conducted in the EU, aiming to create a more favourable environment for medical research in Europe. Given the importance of this Regulation for research, including clinical trials in oncology, the European Society for Medical Oncology (ESMO) will be convening 2 virtual meetings on this topic, with the first one addressing the implications of the new legislation for medical oncology.
ESMO has been actively engaged in the process leading up to the adoption of the Clinical Trials Regulation and worked towards ensuring that medical oncologists are well informed about the impact of the new Regulation on clinical trials in oncology. Thus, given the implications of the Regulation for medical research in Europe, we feel that it is our responsibility to address this important topic, for the benefit of the oncology and health communities, and most importantly for the patients.
The 1st webinar – to be held on 12 October 2021 – will address the Clinical Trials Regulation and its impact on oncology, and it will bring together the perspectives of EU officials, clinical researchers, patients and medical oncologists on the Regulation and how it will affect clinical research in oncology.
- Rosa Giuliani, European Society for Medical Oncology (ESMO)
- Peter Arlett, European Medicines Agency (EMA)
- Stéphanie Kromar, European Organisation for Research and Treatment of Cancer (EORTC)
- Jan Geissler, PATient adVOCATES (Patvocates)
Register for the webinar here.